Skip to main content
. 2019 Jun 7;1(1):20180027. doi: 10.1259/bjro.20180027

Table 4.

Treatment outcome (n = 42)

Number of patients Prostate with rectal spacer (n = 23) Prostate without rectal spacer (n = 10) Prostate bed (n = 9) Total (n = 42)
Follow up duration
Median[range] 21 [3;31] 18 [4;28] 17 [3;20] 21 [3;31]
PFS
Median [range] (months) 10 [3 ; 21] 9 [4 ; 20] 11 [3 ; 17] 11 [3 ; 21]
Site of progression
In field 0 0 0 0
Out field 4 2 1 7 (17%)
-Bones 1 0 0 1 (2%)
-Lymph nodes 3 1 1 5 (12%)
-Bones and lymph nodes 1 0 0 1 (2%)
Biochemical only 0 0 1 1 (2%)